• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于复发性前列腺癌挽救性淋巴结清扫术前的Ga-68-HBED-CC-PSMA配体-PET/CT的诊断准确性

Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.

作者信息

Jilg Cordula A, Drendel Vanessa, Rischke H Christian, Beck Teresa, Vach Werner, Schaal Kathrin, Wetterauer Ulrich, Schultze-Seemann Wolfgang, Meyer Philipp T

机构信息

Department of Urology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Institute for Pathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

出版信息

Theranostics. 2017 Apr 10;7(6):1770-1780. doi: 10.7150/thno.18421. eCollection 2017.

DOI:10.7150/thno.18421
PMID:28529650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5436526/
Abstract

By targeting the prostate-specific membrane antigen (PSMA) on prostate cancer (PCa) cells PSMA-PET/CT shows great potential in locating the site of biochemical recurrence even at low PSA (Prostate-specific antigen)-levels. Accurate imaging of PCa recurrent lymph node metastases (LNM) is crucial for metastases directed therapies such as salvage-lymph node dissection (salvage-LND). To evaluate the diagnostic accuracy of PSMA-PET/CT for detection of affected lymph-node regions at salvage-LND for nodal recurrence of PCa. 30 patients with the suspicion of exclusively nodal PCa-relapse after primary therapy underwent a template pelvic and/or retroperitoneal salvage-LND after whole body 68-Ga-PSMA-PET/CT. The diagnostic accuracy of PET/CT was evaluated in comparison to the histopathology of 965 resected lymph nodes (LN) dissected from 68 main regions (pelvic left/right, retroperitoneal) and 289 subregions (common iliac, external iliac, obturator, internal iliac, presacral, aortic-bifurcation, aortal, caval). LNM and tumor deposits in LNM were measured bidimensionally in the histopathology. PSMA-expression was analyzed by immunohistochemistry in LNM. LNM were present in 11.4% of the resected LN (110/965) resulting in 45 positive main regions and 85 positive subregions. PET/CT was true positive in 41 main regions and 69 subregions. Three PET-negative main regions and 16 PET-negative subregions finally contained LNM, the majority of these false negative subregions (13/16) were in neighboring regions of true-positive subregions. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were: main region-based 93.2%, 100%, 100%, 88.9% and 95.6%, subregion-based 81.2%, 99.5%, 98.6%, 92.7 and 94.1%. Median short diameters of tumor deposits in LNM resected from false-negative subregions (1.3 mm) were significantly smaller than in LNM removed from true-positive subregions (5.5 mm, p<0.0001). Based on anatomical subregions containing just one LNM, the necessary short diameter of tumor deposits in LNM required to reach a detection rate of 50% and 90% was estimated to be ≥ 2.3 mm and ≥ 4.5 mm, respectively. In men with biochemical PCa-relapse and positive PSMA-PET/CT, PET/CT detects metastatic affected anatomical regions with high accuracy at a main region and at a subregion-level. If the decision for salvage-LND is prompted by a positive PSMA-PET/CT, the size of metastases is crucial for accurate detection of affected regions. All LNM showed a clear PSMA-expression in the immunohistochemistry. Further studies need to investigate how to translate the high anatomical correlation observed between PET/CT and surgical findings into optimal approaches for target salvage-LND.

摘要

通过靶向前列腺癌细胞上的前列腺特异性膜抗原(PSMA),PSMA-PET/CT在定位生化复发部位方面显示出巨大潜力,即使在低前列腺特异性抗原(PSA)水平时也是如此。前列腺癌复发性淋巴结转移(LNM)的准确成像对于诸如挽救性淋巴结清扫术(salvage-LND)等转移导向治疗至关重要。为了评估PSMA-PET/CT对前列腺癌淋巴结复发进行挽救性LND时检测受影响淋巴结区域的诊断准确性。30例怀疑原发性治疗后仅发生淋巴结前列腺癌复发的患者在全身68镓PSMA-PET/CT检查后接受了模板化盆腔和/或腹膜后挽救性LND。将PET/CT的诊断准确性与从68个主要区域(盆腔左右、腹膜后)和289个子区域(髂总、髂外、闭孔、髂内、骶前、主动脉分叉、主动脉、腔静脉)切除的965个切除淋巴结(LN)的组织病理学进行比较。在组织病理学中对LNM和LNM中的肿瘤沉积物进行二维测量。通过免疫组织化学分析LNM中的PSMA表达。11.4%的切除LN(110/965)存在LNM,导致45个主要区域和85个子区域呈阳性。PET/CT在41个主要区域和69个子区域为真阳性。三个PET阴性主要区域和16个PET阴性子区域最终含有LNM,这些假阴性子区域中的大多数(13/16)位于真阳性子区域的相邻区域。敏感性、特异性、阳性预测值、阴性预测值和准确性分别为:基于主要区域的93.2%、100%、100%、88.9%和95.6%,基于子区域的81.2%、99.5%、98.6%、92.7%和94.1%。从假阴性子区域切除的LNM中肿瘤沉积物的中位短径(1.3毫米)明显小于从真阳性子区域切除的LNM(5.5毫米,p<0.0001)。基于仅包含一个LNM的解剖子区域,估计LNM中肿瘤沉积物达到50%和90%检测率所需的短径分别≥2.3毫米和≥4.5毫米。在生化前列腺癌复发且PSMA-PET/CT阳性的男性中,PET/CT在主要区域和子区域水平上以高准确性检测转移性受影响解剖区域。如果挽救性LND的决定由阳性PSMA-PET/CT提示,转移灶的大小对于准确检测受影响区域至关重要。所有LNM在免疫组织化学中均显示出明显的PSMA表达。进一步的研究需要调查如何将PET/CT与手术结果之间观察到的高解剖相关性转化为挽救性LND的最佳靶向方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5875/5436526/0cfcc0c602b2/thnov07p1770g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5875/5436526/877157c0b712/thnov07p1770g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5875/5436526/9e721597d238/thnov07p1770g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5875/5436526/0cfcc0c602b2/thnov07p1770g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5875/5436526/877157c0b712/thnov07p1770g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5875/5436526/9e721597d238/thnov07p1770g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5875/5436526/0cfcc0c602b2/thnov07p1770g005.jpg

相似文献

1
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.用于复发性前列腺癌挽救性淋巴结清扫术前的Ga-68-HBED-CC-PSMA配体-PET/CT的诊断准确性
Theranostics. 2017 Apr 10;7(6):1770-1780. doi: 10.7150/thno.18421. eCollection 2017.
2
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值:与挽救性淋巴结切除术后组织病理学的比较。
J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.
3
Detection Rate of F-Choline PET/CT and Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.F-胆碱 PET/CT 和 Ga-PSMA-HBED-CC PET/CT 对前列腺癌淋巴结转移的检出率:与 PET 到组织病理学的直接联系相关,取决于淋巴结中肿瘤沉积的大小。
J Nucl Med. 2019 Jul;60(7):971-977. doi: 10.2967/jnumed.118.220541. Epub 2019 Jan 25.
4
Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer.镓-PSMA 正电子发射断层扫描/计算机断层扫描为前列腺癌患者在淋巴结清扫前提供准确的淋巴结区域分期。
Eur Urol. 2016 Oct;70(4):553-557. doi: 10.1016/j.eururo.2015.12.051. Epub 2016 Jan 19.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
7
Performance of In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.放射性核素标记 PSMA 配体在淋巴结转移性前列腺癌患者中的应用效能:示踪剂摄取与淋巴结清扫术组织病理学之间的相关性。
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2062-2070. doi: 10.1007/s00259-018-4094-0. Epub 2018 Jul 30.
8
Comparison of Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.基于与组织病理学逐片比较,比较镓-羟基苄基乙二胺-N,N'-二乙酸-环糊精前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-HBED-CC PSMA-PET/CT)和多参数磁共振成像(MRI)在原发性前列腺癌患者中检测大体肿瘤体积的情况。
Theranostics. 2017 Jan 1;7(1):228-237. doi: 10.7150/thno.16638. eCollection 2017.
9
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
10
Prospective evaluation of the performance of [Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy.对[镓]镓-PSMA-11 PET/CT(MRI)在根治性前列腺切除术后接受超广泛挽救性淋巴结清扫术患者的淋巴结分期中的性能进行前瞻性评估。
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2169-2177. doi: 10.1007/s00259-019-04361-0. Epub 2019 Jun 29.

引用本文的文献

1
Comparative Analysis of Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for Gross Tumor Volume Delineation in Radiation Therapy Planning of Prostate Cancer.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描与多参数磁共振成像在前列腺癌放射治疗计划中大体肿瘤体积勾画的比较分析
Adv Radiat Oncol. 2025 Jun 9;10(8):101821. doi: 10.1016/j.adro.2025.101821. eCollection 2025 Aug.
2
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final Histology.使用新型SENSEI插入式伽马探头进行机器人辅助PSMA放射性引导挽救性手术治疗寡转移复发性前列腺癌:术中测量与术前成像及最终组织学的相关性
Cancers (Basel). 2024 Dec 31;17(1):93. doi: 10.3390/cancers17010093.
3

本文引用的文献

1
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
2
Value of In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up.前列腺特异性膜抗原(PSMA)放射性引导手术在复发性前列腺癌挽救性淋巴结清扫术中的价值:与组织病理学及临床随访的相关性
BJU Int. 2017 Jul;120(1):40-47. doi: 10.1111/bju.13713. Epub 2016 Dec 4.
3
PSMA PET/CT imaging and its application to prostate cancer treatment.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像及其在前列腺癌治疗中的应用。
Jpn J Radiol. 2025 Jan;43(1):1-12. doi: 10.1007/s11604-024-01646-9. Epub 2024 Sep 3.
4
From foes to friends: rethinking the role of lymph nodes in prostate cancer.从敌人到朋友:重新审视淋巴结在前列腺癌中的作用
Nat Rev Urol. 2024 Nov;21(11):687-700. doi: 10.1038/s41585-024-00912-9. Epub 2024 Aug 2.
5
Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection.前列腺特异性膜抗原靶向手术治疗前列腺癌:准确识别、实时诊断和精确切除。
Theranostics. 2024 Apr 22;14(7):2736-2756. doi: 10.7150/thno.95039. eCollection 2024.
6
How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy.前列腺癌生化复发的管理将如何因治疗的预期和递增概念而改变。
Cancers (Basel). 2024 Feb 13;16(4):764. doi: 10.3390/cancers16040764.
7
[Salvage lymphadenectomy for recurrent prostate cancer].[复发性前列腺癌的挽救性淋巴结清扫术]
Urologie. 2024 Mar;63(3):234-240. doi: 10.1007/s00120-024-02283-w. Epub 2024 Feb 8.
8
Robustness of apparent diffusion coefficient-based lymph node classification for diagnosis of prostate cancer metastasis.基于表观扩散系数的淋巴结分类对前列腺癌转移诊断的稳健性。
Eur Radiol. 2024 Jul;34(7):4504-4515. doi: 10.1007/s00330-023-10406-8. Epub 2023 Dec 15.
9
Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility.前列腺癌前哨淋巴结活检:诊断性能、肿瘤学结局、安全性及可行性概述
Diagnostics (Basel). 2023 Jul 31;13(15):2543. doi: 10.3390/diagnostics13152543.
10
Diagnostic Impact of Dual-Time PET/CT with Gallium-PSMA in Prostate Cancer and Gallium-DOTATOC in Neuroendocrine Tumors.镓标记的PSMA双时相PET/CT在前列腺癌及镓标记的奥曲肽在神经内分泌肿瘤中的诊断价值
Biomedicines. 2023 Mar 29;11(4):1052. doi: 10.3390/biomedicines11041052.
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.
挽救性扩大淋巴结清扫术在前列腺特异抗原(PSA)升高且PET/CT扫描检测到淋巴结复发的前列腺癌患者中的作用
Prostate Cancer Prostatic Dis. 2017 Mar;20(1):85-92. doi: 10.1038/pcan.2016.54. Epub 2016 Nov 8.
4
The use of Ga-PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer.镓-前列腺特异性膜抗原正电子发射断层扫描计算机断层扫描(Ga-PSMA PET CT)在腺泡状前列腺癌根治性治疗后生化复发男性中的应用。
BJU Int. 2016 Oct;118 Suppl 3:49-55. doi: 10.1111/bju.13616. Epub 2016 Sep 23.
5
(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.(68)镓-六氮杂环十二烷四乙酸-环糊精-前列腺特异性膜抗原正电子发射断层显像/计算机断层扫描与原发性局限性前列腺癌组织病理学的体素级比较
Theranostics. 2016 Jun 18;6(10):1619-28. doi: 10.7150/thno.15344. eCollection 2016.
6
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值:与挽救性淋巴结切除术后组织病理学的比较。
J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.
7
Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.在挽救性淋巴结清扫术前,使用(68)Ga-PSMA-HBED-CC检测复发性前列腺癌病灶比使用(18)F-氟乙基胆碱PET/CT更准确。
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1410-7. doi: 10.1007/s00259-016-3366-9. Epub 2016 Mar 19.
8
Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer.镓-PSMA 正电子发射断层扫描/计算机断层扫描为前列腺癌患者在淋巴结清扫前提供准确的淋巴结区域分期。
Eur Urol. 2016 Oct;70(4):553-557. doi: 10.1016/j.eururo.2015.12.051. Epub 2016 Jan 19.
9
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.(68)镓-PSMA 正电子发射断层扫描对 130 例中高危前列腺癌患者淋巴结分期的诊断效能与常规影像学比较。
J Urol. 2016 May;195(5):1436-1443. doi: 10.1016/j.juro.2015.12.025. Epub 2015 Dec 9.
10
Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy.(68)Ga-PSMA PET/CT 成像在根治性前列腺切除术前行高危前列腺癌患者中的初步经验。
Eur Urol. 2016 Mar;69(3):393-6. doi: 10.1016/j.eururo.2015.06.010. Epub 2015 Jun 25.